世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

MEAの遠隔患者モニタリング・ケア市場-2030年までの産業動向と予測


MEA Remote Patient Monitoring and Care Market - Industry Trends and Forecast to 2030

中東・アフリカの遠隔患者モニタリング・ケア市場は、2022年の4億8,843万米ドルから2030年には7億7,102万米ドルに達すると予測され、2023年から2030年の予測期間中の年平均成長率は6.9%である。 市場区分 中... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ 		2023年5月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		172 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

中東・アフリカの遠隔患者モニタリング・ケア市場は、2022年の4億8,843万米ドルから2030年には7億7,102万米ドルに達すると予測され、2023年から2030年の予測期間中の年平均成長率は6.9%である。

市場区分
中東およびアフリカの遠隔患者モニタリングおよびケア市場：デバイスタイプ別（心臓モニタリングデバイス、血圧モニタリングデバイス、血糖モニタリングデバイス、呼吸モニタリングデバイス、神経モニタリングデバイス、マルチパラメータモニタリングデバイス、その他）、用途別（腫瘍学、糖尿病、心血管疾患、その他）、エンドユーザー別（病院ベースの患者、外来患者、在宅医療患者）、国別（南アフリカ、サウジアラビア、U.A.E.、エジプト、イスラエル、中東およびアフリカのその他）-産業動向と2030年までの予測


中東・アフリカのアカウント遠隔患者モニタリングとケア市場ダイナミクスの概要

推進要因
- 慢性疾患の増加

抑制要因

- 厳しい規制の枠組み

機会

- 市場プレーヤーによる戦略的イニシアティブ

市場プレイヤー
中東・アフリカの遠隔患者モニタリング・ケア市場で事業を展開する主な市場プレイヤーを以下に挙げる：
- メドトロニック
- ボストン・サイエンティフィック社
- バイタルコネクト
- バイオビート
- ゼネラル・エレクトリック
- フィリップスN.V.
- オムロン株式会社
- アボット
- 日本光電工業株式会社
- ビビファイヘルス株式会社
- アエロテル・メディカル・システムズ
- BIOTRONIK SE & Co.KG
- エー・アンド・デイ株式会社
- アライブコア社
- マシモ
- デックスコム社
- センスオニクス社
- レスメッド
- 100プラス
- クロニセンスメディカル
- ヴィトルス
- カルディオモ
- コーチケア
- ネティエラ
- ウィジングス


ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER’S FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 MIDDLE EAST AND AFRICA 96
9.1.1 SOUTH AFRICA 104
9.1.2 EGYPT 108
9.1.3 ISRAEL 112
9.1.4 UAE 116
9.1.5 SAUDI ARABIA 120
9.1.6 REST OF MIDDLE EAST AND AFRICA 124
10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 125
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 125
11 SWOT ANALYSIS 126
12 COMPANY PROFILE 127
12.1 MEDTRONIC 127
12.1.1 COMPANY SNAPSHOT 127
12.1.2 REVENUE ANALYSIS 128
12.1.3 COMPANY SHARE ANALYSIS 128
12.1.4 PRODUCT PORTFOLIO 129
12.1.5 RECENT DEVELOPMENT 129
12.2 DEXCOM, INC. 130
12.2.1 COMPANY SNAPSHOT 130
12.2.2 REVENUE ANALYSIS 130
12.2.3 COMPANY SHARE ANALYSIS 131
12.2.4 PRODUCT PORTFOLIO 131
12.2.5 RECENT DEVELOPMENT 131
12.3 ABBOTT 132
12.3.1 COMPANY SNAPSHOT 132
12.3.2 REVENUE ANALYSIS 132
12.3.3 COMPANY SHARE ANALYSIS 133
12.3.4 PRODUCT PORTFOLIO 133
12.3.5 RECENT DEVELOPMENT 133
12.4 RESMED 134
12.4.1 COMPANY SNAPSHOT 134
12.4.2 REVENUE ANALYSIS 134
12.4.3 COMPANY SHARE ANALYSIS 135
12.4.4 PRODUCT PORTFOLIO 135
12.4.5 RECENT DEVELOPMENT 135
12.5 BIOTRONIK SE & CO. KG 136
12.5.1 COMPANY SNAPSHOT 136
12.5.2 COMPANY SHARE ANALYSIS 136
12.5.3 PRODUCT PORTFOLIO 137
12.5.4 RECENT DEVELOPMENT 137
12.6 100 PLUS. 138
12.6.1 COMPANY SNAPSHOT 138
12.6.2 PRODUCT PORTFOLIO 138
12.6.3 RECENT DEVELOPMENTS 138
12.7 A&D COMPANY, LIMITED 139
12.7.1 COMPANY SNAPSHOT 139
12.7.2 REVENUE ANALYSIS 139
12.7.3 COMPANY SHARE ANALYSIS 140
12.7.4 PRODUCT PORTFOLIO 140
12.7.5 RECENT DEVELOPMENT 140
12.8 AEROTEL MEDICAL SYSTEMS 141
12.8.1 COMPANY SNAPSHOT 141
12.8.2 PRODUCT PORTFOLIO 141
12.8.3 RECENT DEVELOPMENT 141
12.9 ALIVECOR, INC. 142
12.9.1 COMPANY SNAPSHOT 142
12.9.2 COMPANY SHARE ANALYSIS 142
12.9.3 PRODUCT PORTFOLIO 142
12.9.4 RECENT DEVELOPMENTS 143
12.10 BIOBEAT 144
12.10.1 COMPANY SNAPSHOT 144
12.10.2 PRODUCT PORTFOLIO 144
12.10.3 RECENT DEVELOPMENT 144
12.11 BOSTON SCIENTIFIC CORPORATION 145
12.11.1 COMPANY SNAPSHOT 145
12.11.2 REVENUE ANALYSIS 146
12.11.3 COMPANY SHARE ANALYSIS 146
12.11.4 PRODUCT PORTFOLIO 146
12.11.5 RECENT DEVELOPMENT 147
12.12 CARDIOMO 148
12.12.1 COMPANY SNAPSHOT 148
12.12.2 PRODUCT PORTFOLIO 148
12.12.3 RECENT DEVELOPMENTS 148
12.13 CHRONISENSE MEDICAL, LTD. 149
12.13.1 COMPANY SNAPSHOT 149
12.13.2 PRODUCT PORTFOLIO 149
12.13.3 RECENT DEVELOPMENT 149
12.14 COACHCARE 150
12.14.1 COMPANY SNAPSHOT 150
12.14.2 PRODUCT PORTFOLIO 150
12.14.3 RECENT DEVELOPMENT 150
12.15 GENERAL ELECTRIC 151
12.15.1 COMPANY SNAPSHOT 151
12.15.2 REVENUE ANALYSIS 151
12.15.3 COMPANY SHARE ANALYSIS 152
12.15.4 PRODUCT PORTFOLIO 152
12.15.5 RECENT DEVELOPMENT 152
12.16 KONINKLIJKE PHILIPS N.V. 153
12.16.1 COMPANY SNAPSHOT 153
12.16.2 REVENUE ANALYSIS 153
12.16.3 COMPANY SHARE ANALYSIS 154
12.16.4 PRODUCT PORTFOLIO 154
12.16.5 RECENT DEVELOPMENT 154
12.17 MASIMO 155
12.17.1 COMPANY SNAPSHOT 155
12.17.2 REVENUE ANALYSIS 155
12.17.3 COMPANY SHARE ANALYSIS 156
12.17.4 PRODUCT PORTFOLIO 156
12.17.5 RECENT DEVELOPMENT 156
12.18 NETEERA 157
12.18.1 COMPANY SNAPSHOT 157
12.18.2 PRODUCT PORTFOLIO 157
12.18.3 RECENT DEVELOPMENT 157
12.19 NIHON KOHDEN CORPORATION 158
12.19.1 COMPANY SNAPSHOT 158
12.19.2 REVENUE ANALYSIS 158
12.19.3 COMPANY SHARE ANALYSIS 159
12.19.4 PRODUCT PORTFOLIO 159
12.19.5 RECENT DEVELOPMENT 159
12.20 OMRON CORPORATION 160
12.20.1 COMPANY SNAPSHOT 160
12.20.2 REVENUE ANALYSIS 160
12.20.3 COMPANY SHARE ANALYSIS 161
12.20.4 PRODUCT PORTFOLIO 161
12.20.5 RECENT DEVELOPMENT 161
12.21 SENSEONICS, INC. 162
12.21.1 COMPANY SNAPSHOT 162
12.21.2 REVENUE ANALYSIS 162
12.21.3 COMPANY SHARE ANALYSIS 163
12.21.4 PRODUCT PORTFOLIO 163
12.21.5 RECENT DEVELOPMENT 163
12.22 VITALCONNECT 164
12.22.1 COMPANY SNAPSHOT 164
12.22.2 PRODUCT PORTFOLIO 164
12.22.3 RECENT DEVELOPMENT 164
12.23 VITLS 165
12.23.1 COMPANY SNAPSHOT 165
12.23.2 PRODUCT PORTFOLIO 165
12.23.3 RECENT DEVELOPMENT 165
12.24 VIVIFY HEALTH INC. 166
12.24.1 COMPANY SNAPSHOT 166
12.24.2 PRODUCT PORTFOLIO 166
12.24.3 RECENT DEVELOPMENTS 166
12.25 WITHINGS 167
12.25.1 COMPANY SNAPSHOT 167
12.25.2 COMPANY SHARE ANALYSIS 167
12.25.3 PRODUCT PORTFOLIO 167
12.25.4 RECENT DEVELOPMENT 168
13 QUESTIONNAIRE 169
14 RELATED REPORTS 172

　

ページTOPに戻る


　

Summary

The Middle East and Africa remote patient monitoring and care market is expected to reach USD 771.02 million by 2030 from USD 488.43 million in 2022, growing at a CAGR of 6.9% during the forecast period of 2023 to 2030.

Market Segmentation
Middle East and Africa Remote Patient Monitoring and Care Market, By Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital Based Patients, Ambulatory Patients, and Home Healthcare Patients), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030


Overview of Middle East and Africa Accounts Remote Patient Monitoring and Care Market Dynamics

Driver
• Increasing prevalence of chronic diseases

Restraint

• Stringent regulatory framework

Opportunity

• Strategic initiatives by market players

Market Players
Some of the major market players operating in the Middle East and Africa remote patient monitoring and care market are:
• Medtronic
• Boston Scientific Corporation
• VitalConnect
• Biobeat
• General Electric
• Koninklijke Philips N.V.
• OMRON Corporation
• Abbott
• Nihon Kohden Corporation
• Vivify Health, Inc.
• Aerotel Medical Systems
• BIOTRONIK SE & Co. KG
• A&D Company, Limited
• AliveCor, Inc.
• Masimo
• Dexcom, Inc.
• Senseonics, Inc.
• ResMed
• 100Plus.
• ChroniSense Medical, Ltd.
• Vitls
• Cardiomo
• CoachCare
• neteera
• Withings



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER’S FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 MIDDLE EAST AND AFRICA 96
9.1.1 SOUTH AFRICA 104
9.1.2 EGYPT 108
9.1.3 ISRAEL 112
9.1.4 UAE 116
9.1.5 SAUDI ARABIA 120
9.1.6 REST OF MIDDLE EAST AND AFRICA 124
10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 125
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 125
11 SWOT ANALYSIS 126
12 COMPANY PROFILE 127
12.1 MEDTRONIC 127
12.1.1 COMPANY SNAPSHOT 127
12.1.2 REVENUE ANALYSIS 128
12.1.3 COMPANY SHARE ANALYSIS 128
12.1.4 PRODUCT PORTFOLIO 129
12.1.5 RECENT DEVELOPMENT 129
12.2 DEXCOM, INC. 130
12.2.1 COMPANY SNAPSHOT 130
12.2.2 REVENUE ANALYSIS 130
12.2.3 COMPANY SHARE ANALYSIS 131
12.2.4 PRODUCT PORTFOLIO 131
12.2.5 RECENT DEVELOPMENT 131
12.3 ABBOTT 132
12.3.1 COMPANY SNAPSHOT 132
12.3.2 REVENUE ANALYSIS 132
12.3.3 COMPANY SHARE ANALYSIS 133
12.3.4 PRODUCT PORTFOLIO 133
12.3.5 RECENT DEVELOPMENT 133
12.4 RESMED 134
12.4.1 COMPANY SNAPSHOT 134
12.4.2 REVENUE ANALYSIS 134
12.4.3 COMPANY SHARE ANALYSIS 135
12.4.4 PRODUCT PORTFOLIO 135
12.4.5 RECENT DEVELOPMENT 135
12.5 BIOTRONIK SE & CO. KG 136
12.5.1 COMPANY SNAPSHOT 136
12.5.2 COMPANY SHARE ANALYSIS 136
12.5.3 PRODUCT PORTFOLIO 137
12.5.4 RECENT DEVELOPMENT 137
12.6 100 PLUS. 138
12.6.1 COMPANY SNAPSHOT 138
12.6.2 PRODUCT PORTFOLIO 138
12.6.3 RECENT DEVELOPMENTS 138
12.7 A&D COMPANY, LIMITED 139
12.7.1 COMPANY SNAPSHOT 139
12.7.2 REVENUE ANALYSIS 139
12.7.3 COMPANY SHARE ANALYSIS 140
12.7.4 PRODUCT PORTFOLIO 140
12.7.5 RECENT DEVELOPMENT 140
12.8 AEROTEL MEDICAL SYSTEMS 141
12.8.1 COMPANY SNAPSHOT 141
12.8.2 PRODUCT PORTFOLIO 141
12.8.3 RECENT DEVELOPMENT 141
12.9 ALIVECOR, INC. 142
12.9.1 COMPANY SNAPSHOT 142
12.9.2 COMPANY SHARE ANALYSIS 142
12.9.3 PRODUCT PORTFOLIO 142
12.9.4 RECENT DEVELOPMENTS 143
12.10 BIOBEAT 144
12.10.1 COMPANY SNAPSHOT 144
12.10.2 PRODUCT PORTFOLIO 144
12.10.3 RECENT DEVELOPMENT 144
12.11 BOSTON SCIENTIFIC CORPORATION 145
12.11.1 COMPANY SNAPSHOT 145
12.11.2 REVENUE ANALYSIS 146
12.11.3 COMPANY SHARE ANALYSIS 146
12.11.4 PRODUCT PORTFOLIO 146
12.11.5 RECENT DEVELOPMENT 147
12.12 CARDIOMO 148
12.12.1 COMPANY SNAPSHOT 148
12.12.2 PRODUCT PORTFOLIO 148
12.12.3 RECENT DEVELOPMENTS 148
12.13 CHRONISENSE MEDICAL, LTD. 149
12.13.1 COMPANY SNAPSHOT 149
12.13.2 PRODUCT PORTFOLIO 149
12.13.3 RECENT DEVELOPMENT 149
12.14 COACHCARE 150
12.14.1 COMPANY SNAPSHOT 150
12.14.2 PRODUCT PORTFOLIO 150
12.14.3 RECENT DEVELOPMENT 150
12.15 GENERAL ELECTRIC 151
12.15.1 COMPANY SNAPSHOT 151
12.15.2 REVENUE ANALYSIS 151
12.15.3 COMPANY SHARE ANALYSIS 152
12.15.4 PRODUCT PORTFOLIO 152
12.15.5 RECENT DEVELOPMENT 152
12.16 KONINKLIJKE PHILIPS N.V. 153
12.16.1 COMPANY SNAPSHOT 153
12.16.2 REVENUE ANALYSIS 153
12.16.3 COMPANY SHARE ANALYSIS 154
12.16.4 PRODUCT PORTFOLIO 154
12.16.5 RECENT DEVELOPMENT 154
12.17 MASIMO 155
12.17.1 COMPANY SNAPSHOT 155
12.17.2 REVENUE ANALYSIS 155
12.17.3 COMPANY SHARE ANALYSIS 156
12.17.4 PRODUCT PORTFOLIO 156
12.17.5 RECENT DEVELOPMENT 156
12.18 NETEERA 157
12.18.1 COMPANY SNAPSHOT 157
12.18.2 PRODUCT PORTFOLIO 157
12.18.3 RECENT DEVELOPMENT 157
12.19 NIHON KOHDEN CORPORATION 158
12.19.1 COMPANY SNAPSHOT 158
12.19.2 REVENUE ANALYSIS 158
12.19.3 COMPANY SHARE ANALYSIS 159
12.19.4 PRODUCT PORTFOLIO 159
12.19.5 RECENT DEVELOPMENT 159
12.20 OMRON CORPORATION 160
12.20.1 COMPANY SNAPSHOT 160
12.20.2 REVENUE ANALYSIS 160
12.20.3 COMPANY SHARE ANALYSIS 161
12.20.4 PRODUCT PORTFOLIO 161
12.20.5 RECENT DEVELOPMENT 161
12.21 SENSEONICS, INC. 162
12.21.1 COMPANY SNAPSHOT 162
12.21.2 REVENUE ANALYSIS 162
12.21.3 COMPANY SHARE ANALYSIS 163
12.21.4 PRODUCT PORTFOLIO 163
12.21.5 RECENT DEVELOPMENT 163
12.22 VITALCONNECT 164
12.22.1 COMPANY SNAPSHOT 164
12.22.2 PRODUCT PORTFOLIO 164
12.22.3 RECENT DEVELOPMENT 164
12.23 VITLS 165
12.23.1 COMPANY SNAPSHOT 165
12.23.2 PRODUCT PORTFOLIO 165
12.23.3 RECENT DEVELOPMENT 165
12.24 VIVIFY HEALTH INC. 166
12.24.1 COMPANY SNAPSHOT 166
12.24.2 PRODUCT PORTFOLIO 166
12.24.3 RECENT DEVELOPMENTS 166
12.25 WITHINGS 167
12.25.1 COMPANY SNAPSHOT 167
12.25.2 COMPANY SHARE ANALYSIS 167
12.25.3 PRODUCT PORTFOLIO 167
12.25.4 RECENT DEVELOPMENT 168
13 QUESTIONNAIRE 169
14 RELATED REPORTS 172

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（電池）の最新刊レポート

Data Bridge Market Research 社の最新刊レポート

本レポートと同じKEY WORD（mea）の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/09　10:27

143.78 円

159.73 円

191.51 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.